Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
BME Frontiers is Scopus-indexed (Q1, CiteScore 12.4), WoS ESCI, DOAJ. Published by American Association for the Advancement of Science.
Checked against the index lists dated .
ISSN 2765-8031Verify ISSN ↗
Publisher: American Association for the Advancement of Science
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 30 / 466 | 93rd | Q1 |
| Biomedical Engineering | 42 / 342 | 87th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q1, CiteScore 12.4.
BME Frontiers is Q1 in Medicine (miscellaneous) (rank 30 of 466) and Q1 in Biomedical Engineering (rank 42 of 342), by CiteScore 2025.
BME Frontiers is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 12.4, which places it in quartile Q1 at the 93rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.389, quartile Q1, with an H-index of 24.
BME Frontiers is published by American Association for the Advancement of Science. Its ISSN is 2765-8031.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
BME Frontiers has an h-index of 33 and a 2-year mean of 10.56 citations per paper (OpenAlex). Its Scopus CiteScore is 12.4, quartile Q1. On 2-year citations it ranks #9 of 451 Scopus journals in Medicine (miscellaneous).
BME Frontiers published 36 papers in 2025; its busiest recent year was 2022 with 43. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2023–2026), authors are most often from China (49.6%), United States (28.2%) and India (4.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.